CORD-19:775b90287b44353bee979abb0970a4666022f86d / 134717-134940 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"A recent breakthrough treatment with recombinant enzyme replacement has significantly improved patients' survival, but is often complicated by the development of enzyme specific antibodies precluding further administration.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T86968","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T86968","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T345","span":{"begin":0,"end":223},"obj":"Sentence"}],"attributes":[{"subj":"T345","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ece6","default":true},{"id":"CORD-19_Custom_license_subset","color":"#eccb93"}]}]}}